|
|
|
|
|
| Sequeira,J.L.; Franco,M.; Bandarra,E.P.; Figueiredo,L.M.A.; Rocha,N.S.. |
| Estudaram-se as características anatomoclínicas dos linfomas em cães da região de Botucatu, São Paulo. O material utilizado foi colhido de 34 cães portadores de linfoma maligno, dos quais nove eram da raça Pastor-Alemão, nove sem raça definida, cinco da raça Boxer, três animais da raça Dobermann e oito outros cada um de uma raça, 68% deles machos. A idade variou de 1 a 13 anos, com média de 6,2 anos. O estabelecimento do estádio dos linfomas foi baseado nos critérios estabelecidos pela Organização Mundial de Saúde. No momento do diagnóstico, 32 animais apresentavam-se nos estádios clínicos III, IV ou V. Apenas dois foram enquadrados no estádio II. A forma anatômica mais freqüente foi a multicêntrica, diagnosticada em 31 animais. A forma tímica,... |
| Tipo: Info:eu-repo/semantics/article |
Palavras-chave: Cão; Linfoma; Neoplasia. |
| Ano: 1999 |
URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09351999000300008 |
| |
|
| |
|
| |
|
|
| Matsubara,B.B.; Franco,M.; Janicki,J.S.; Matsubara,L.S.. |
| It has been recently shown that calcium channel blockers might have a protective effect on cardiac fibrogenesis induced by aldosterone. The objective of this study was to evaluate the protective effect of felodipine, a dihydropyridine calcium channel blocker, against heart and kidney damage caused by aldosterone-high sodium intake in uninephrectomized rats. Wistar rats were divided into three groups: CNEP (uninephrectomized + 1% NaCl in the drinking water, N = 9); ALDO (same as CNEP group plus continuous infusion of 0.75 µg/h aldosterone, N = 12); ALDOF (same as ALDO group plus 30 mg·kg-1·day-1 felodipine in the drinking water, N = 10). All results were compared with those of age-matched, untreated rats (CTL group, N = 10). After 6 weeks, tail cuff blood... |
| Tipo: Info:eu-repo/semantics/article |
Palavras-chave: Aldosterone; Dihydropyridine; Fibrinoid necrosis; Vascular remodeling; Hypertension; Myocardial remodeling. |
| Ano: 2010 |
URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2010000500013 |
| |
|
|
| Shulzhenko,N.; Morgun,A.; Franco,M.; Souza,M.M.; Almeida,D.R.; Diniz,R.V.Z.; Carvalho,A.C.C.; Pacheco-Silva,A.; Gerbase-DeLima,M.. |
| The purpose of the present study was to investigate the expression (mRNA) of CD40 ligand (CD40L), interferon-gamma (IFN-gamma) and Fas ligand (FasL) genes in human cardiac allografts in relation to the occurrence of acute cardiac allograft rejection as well as its possible value in predicting acute rejection. The mRNA levels were determined by a semiquantitative reverse transcriptase-polymerase chain reaction method in 39 samples of endomyocardial biopsies obtained from 10 adult cardiac transplant recipients within the first six months after transplantation. Biopsies with ongoing acute rejection showed significantly higher CD40L, IFN-gamma and FasL mRNA expression than biopsies without rejection. The median values of mRNA expression in biopsies with and... |
| Tipo: Info:eu-repo/semantics/other |
Palavras-chave: Rejection; Cardiac allograft; Immunologic monitoring; MRNA; Gene activation; Interferon-gamma. |
| Ano: 2001 |
URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2001000600013 |
| |
|
|
| Silva,L.A.; Felipe,C.R.; Park,S.I.; Pinheiro-Machado,P.; Garcia,R.; Franco,M.; Moreira,S.R.; Tedesco-Silva Jr.,H.; Medina-Pestana,J.. |
| We conducted a retrospective analysis of the influence of full doses of calcineurin inhibitors [8-10 mg kg-1 day-1 cyclosporine (N = 80), or 0.2-0.3 mg kg-1 day-1 tacrolimus (N = 68)] administered from day 1 after transplantation on the transplant outcomes of a high-risk population. Induction therapy was used in 13% of the patients. Patients also received azathioprine (2 mg kg-1 day-1, N = 58) or mycophenolate mofetil (2 g/day, N = 90), and prednisone (0.5 mg kg-1 day-1, N = 148). Mean time on dialysis was 79 ± 41 months, 12% of the cases were re-transplants, and 21% had panel reactive antibodies >10%. In 43% of donors the cause of death was cerebrovascular disease and 27% showed creatinine above 1.5 mg/dL. The incidence of slow graft function (SGF) and... |
| Tipo: Info:eu-repo/semantics/article |
Palavras-chave: Cyclosporine; Tacrolimus; Delayed graft function; Graft function; Kidney transplantation. |
| Ano: 2006 |
URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006000100005 |
| |
|
|
| Machado,P.G.P.; Felipe,C.R.; Park,S.I.; Garcia,R.; Moreira,S.; Casarini,D.; Franco,M.; Alfieri,F.; Tedesco-Silva Jr.,H.; Medina-Pestana,J.O.. |
| The use of sirolimus (SRL) in combination with full doses of cyclosporin A (CsA) results in reduced one-year kidney allograft function, which is associated with shorter long-term allograft survival. We determined the effect of reduced CsA exposure on graft function in patients receiving SRL and prednisone. Ninety recipients of living kidney transplants receiving SRL (2 mg/day, po) were compared to 35 recipients receiving azathioprine (AZA, 2 mg kg-1 day-1, po). All patients also received CsA (8-10 mg kg-1 day-1, po) and prednisone (0.5 mg kg-1 day-1). Efficacy end-point was a composite of biopsy-confirmed acute rejection, graft loss, or death at one year. Graft function was measured by creatinine, creatinine clearance, and graft function deterioration... |
| Tipo: Info:eu-repo/semantics/article |
Palavras-chave: Sirolimus; Cyclosporine; Graft function; Immunosuppression; Kidney transplantation. |
| Ano: 2004 |
URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2004000900004 |
| |
|
|
|
